Seekwell

Company Overview

Snapshot

Founded in May 2018 by Ron Shimoni, Eden Firuz, and Oded Shoseyov, Seekwell operates with 1–10 employees. The company has raised $4 million across one funding round from one investor. In February 2022, Seekwell secured $4 million in Seed funding from BOL (Breath of Life) Pharma.

Business overview

Seekwell is a Health Tech & Life Sciences company specializing in cannabis-based therapeutics. The company has developed a technology that uses proprietary AI-assisted processes and biochemical analysis to match hemp-based formulations to specific medical and physical indications. Seekwell's platform aims to provide partners with a stable supply chain for its products, targeting an expanding variety of medical indications within the Pharmaceuticals sector, particularly Medical Cannabis, and serving consumers and patients, especially women.

Strategic signal

In February 2022, Seekwell secured $4 million in Seed funding from BOL (Breath of Life) Pharma. This investment signals strategic validation for Seekwell's AI-assisted cannabis formulation technology and its potential in the medical cannabis market, demonstrating investor confidence in its approach to matching hemp-based therapeutics to specific medical indications.

Company Intelligence Q&A

What is Seekwell's primary focus?

Seekwell focuses on developing cannabis-based therapeutics, utilizing AI-assisted processes to match hemp-based formulations to specific medical indications.

When was Seekwell founded?

Seekwell was founded in May 2018.

Who are the founders of Seekwell?

Seekwell was co-founded by Ron Shimoni, Eden Firuz, and Oded Shoseyov.

What was a significant funding event for Seekwell?

In February 2022, Seekwell secured $4 million in Seed funding from BOL (Breath of Life) Pharma.

What is the current operational status of Seekwell?

Seekwell ceased to operate in June 2026.